Literature DB >> 27783319

Expecting the holistic regulation from Chinese medicine based on the "solar system" hypothesis of ischemic heart disease.

Jing Luo1, An-Lu Wang2, Hao Xu3, Da-Zhuo Shi4, Ke-Ji Chen5.   

Abstract

Stenosis of the coronary artery has been considered as an essential component of ischemic heart disease (IHD). Consequently, revascularization [e.g., percutaneous coronary intervention (PCI) and coronary artery bypass] has been the primary therapeutic approach to IHD. Such strategy has indeed revolutionized the management of IHD patients. However, not all patients with myocardial ischemia have visible coronary stenosis. Moreover, cardiovascular events occur in nearly 20% patients with stable coronary artery disease who have undergone PCI. The recently proposed "solar system" hypothesis of IHD postulates that coronary stenosis is only one (albeit important) of its features. Mechanistic contribution and clinical implication of multiple pathophysiological processes beyond coronary stenosis are highlighted in this hypothesis. On the basis of a holistic regulation and individualized medicine, Chinese medicine (CM) has been used in the real-world setting to manage a variety of diseases, including IHD, for more than two thousands years. In this article, we summarize the evidence of CM that supports the "solar system" IHD hypothesis, and argue for a comprehensive approach to IHD. At the theoretical level, the central features of this approach include a holistic view of disease and human subjects, as well as individualized medicine. At the practical level, this approach emphasizes anoxia-tolerance and self-healing.

Entities:  

Keywords:  Chinese medicine; coronary heart disease; holistic regulation; ischemic heart disease; myocardial ischemia

Mesh:

Year:  2016        PMID: 27783319     DOI: 10.1007/s11655-016-2267-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  47 in total

Review 1.  Rhodiola rosea: a possible plant adaptogen.

Authors:  G S Kelly
Journal:  Altern Med Rev       Date:  2001-06

2.  Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reaction.

Authors:  Huilin Hu; Changlin Zhai; Gang Qian; Aiming Gu; Jialiang Liu; Fang Ying; Wenbo Xu; Dandan Jin; Huawei Wang; Haizhen Hu; Yingqing Zhang; Guanmin Tang
Journal:  Pharm Biol       Date:  2015-04-13       Impact factor: 3.503

3.  Effects of Shenshao Decoction on the inflammatory response in the aorta of a rat atherosclerotic model.

Authors:  Zhong-Wen Xue; Xiao-Ming Shang; Song-Hui Lv; Hong Xu; Qi Zhang; Chen Wang
Journal:  Chin J Integr Med       Date:  2013-05-15       Impact factor: 1.978

4.  MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.

Authors:  Maliheh Nazari-Jahantigh; Yuanyuan Wei; Heidi Noels; Shamima Akhtar; Zhe Zhou; Rory R Koenen; Kathrin Heyll; Felix Gremse; Fabian Kiessling; Jochen Grommes; Christian Weber; Andreas Schober
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

Review 5.  Coronary microvascular dysfunction in the clinical setting: from mystery to reality.

Authors:  Joerg Herrmann; Juan Carlos Kaski; Amir Lerman
Journal:  Eur Heart J       Date:  2012-08-22       Impact factor: 29.983

6.  Dihydrotanshinone, a lipophilic component of Salvia miltiorrhiza (danshen), relaxes rat coronary artery by inhibition of calcium channels.

Authors:  Francis F Y Lam; John H K Yeung; Kam M Chan; Penelope M Y Or
Journal:  J Ethnopharmacol       Date:  2008-07-18       Impact factor: 4.360

7.  Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins.

Authors:  Tiejun Wu; Heping Zhou; Zhenxiao Jin; Shenghui Bi; Xiuling Yang; Dinghua Yi; Weiyong Liu
Journal:  Eur J Pharmacol       Date:  2009-04-17       Impact factor: 4.432

8.  Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway.

Authors:  Jinping Zhang; Anheng Liu; Rongrong Hou; Juan Zhang; Xin Jia; Weifeng Jiang; Jianzong Chen
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

9.  Effects of Radix et Rhizoma Rhodiolae Kirilowii on expressions of von Willebrand factor, hypoxia-inducible factor 1 and vascular endothelial growth factor in myocardium of rats with acute myocardial infarction.

Authors:  Xiu-fang Gao; Hai-ming Shi; Tao Sun; Hong Ao
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2009-05

10.  Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter Study.

Authors:  Shao-Li Wang; Cheng-Long Wang; Pei-Li Wang; Hao Xu; Hong-Ying Liu; Jian-Peng Du; Da-Wu Zhang; Zhu-Ye Gao; Lei Zhang; Chang-Geng Fu; Shu-Zheng Lü; Shi-Jie You; Jun-Bo Ge; Tian-Chang Li; Xian Wang; Guan-Lin Yang; Hong-Xu Liu; Jing-Yuan Mao; Rui-Jie Li; Li-Dian Chen; Shu Lu; Da-Zhuo Shi; Ke-Ji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.